ELVN
#1679
Enliven Therapeutics, Inc. - Common Stock
50.8 7 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.43%
Monthly Change
+11.48%
6 month change
+94.23%
Year Change
+146.22%
Previous Close
51.0 9
Open
50.8 7
Low
50.8 7
High
50.8 7
Volume
74
Financials
- Market Capitalization 3.1 B
- Employee 61
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.42
Price to sales ratio
-8 232.35
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1661 |  BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD | ||
| 1663 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.15 USD | -2.27% | -7.85% | +22.83% | +10.96% | 3.18 B USD | ||
| 1701 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 38.53 USD | -1.48% | +1.39% | +21.47% | +41.45% | 3.02 B USD | ||
| 1713 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 41.50 USD | -1.19% | +3.03% | +19.70% | +39.54% | 2.98 B USD |
Frequently asked questions about Enliven Therapeutics, Inc. - Common Stock
What is the Enliven Therapeutics, Inc. - Common Stock stock price today?
The current price of Enliven Therapeutics, Inc. - Common Stock (ELVN) is 50.87. Over the past 24 hours, the stock has changed by -0.43%. Follow the ELVN chart for real-time price dynamics.
What is the stock ticker of Enliven Therapeutics, Inc. - Common Stock?
Enliven Therapeutics, Inc. - Common Stock trades under the ticker ELVN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Enliven Therapeutics, Inc. - Common Stock stock going up?
ELVN has changed by +1.27% over the last week, +11.48% over the last month, and +146.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Enliven Therapeutics, Inc. - Common Stock net income for the last quarter?
Enliven Therapeutics, Inc. - Common Stock reported net income of -23.63 M for the last quarter. The previous quarter showed -29.67 M, which means net income changed by +20.36%.
How many employees does Enliven Therapeutics, Inc. - Common Stock have?
As of the latest available data, Enliven Therapeutics, Inc. - Common Stock has 61 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Enliven Therapeutics, Inc. - Common Stock stock?
You can buy Enliven Therapeutics, Inc. - Common Stock (ELVN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Enliven Therapeutics, Inc. - Common Stock stock?
Investing in Enliven Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELVN chart and related analysis on metatrader.com as part of your research.